Industry Programs are a promotional activity and are not approved for continuing education credit unless otherwise noted. The content and opinions expressed by presenters are those of the sponsor or presenter and are not supported, endorsed, or accredited by the American Thoracic Society.
Browse by Category:
Featured
Reconsidering the Diagnosis: Could it be CF?
Innovation Theater 8
Supported by: Vertex Pharmaceuticals Incorporated
Beyond the Airway: Conversations That Shape Severe Asthma Treatment Decisions
Innovation Theater 4
Supported by: GSK
The Duality of IL-33 in COPD: Inflammation and Mucus Dysfunction with Dr Monica Kraft, MD
Innovation Theater 5
Supported by: AstraZeneca
Turning Down the Inflammatory Signal in COPD: Advancing Care With Biologic Therapies Targeting Upstream Cytokines
Hyatt Regency, Windemere Ballroom X
Supported by: PVI, PeerView Institute for Medical Education
Look Beyond COPD & Severe Asthma: The Role of AAT Protein in Lung Health
Hyatt Regency, Regency R
Supported by: Sanofi
Illuminating Pathways in Epithelial-Driven Inflammation: Evolving Management of Upper and Lower Airway Diseases
Hilton Orlando Florida Ballroom 1-4
Supported by: An educational grant from AstraZeneca
Gaining Control of Eosinophilic Disorders: Best Practices for Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
Rosen Center, Executive H
Supported by: AstraZeneca
Transforming Care in Bronchiectasis: From Myths to Modern Management
Rosen Plaza, Ballroom A / Livestream |
Supported by: an Educational Grant from Insmed.
IL-33 in the Spotlight: Exploring New Pathways for COPD and Acute Respiratory Infections
Hilton Orlando, Florida Ballroom 1-4
Supported by: An educational grant from AstraZeneca
Bronchiectasis Care With BRINSUPRI: The First Approval in NCFB
Innovation Theater 6
Supported by: Insmed